Lv3
220 积分 2026-05-11 加入
Development of potent JAK1/2 PROTAC degraders for the treatment of inflammatory bowel diseases
3天前
已完结
Current and emerging therapeutic targets for IBD
1个月前
已完结
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease
1个月前
已完结
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions
1个月前
已完结
Gut microbial healing in IBD: visionary approach or evidence-based reality?
1个月前
已完结
Crohn's disease
1个月前
已完结
Ulcerative colitis
1个月前
已完结
皖公网安备34019202002308
